Company Overview

Medline Industries, Inc. is a privately held healthcare company specializing in the manufacture and distribution of medical supplies, devices, and solutions. The company operates primarily within the healthcare products manufacturing, medical distribution, and healthcare supply chain services industries. Medline’s core offerings span consumable medical supplies, clinical solutions, and capital equipment used across acute care hospitals, surgery centers, long-term care facilities, and home healthcare environments. Its vertically integrated model—encompassing product design, manufacturing, and distribution—positions Medline as one of the largest privately owned medical supply companies in the United States.

Founded in 1966, Medline began as a regional supplier of hospital linens and has evolved into a global healthcare manufacturer and distributor with a broad product portfolio. Over several decades, the company expanded through organic growth, private-label manufacturing, and strategic acquisitions, enabling it to compete with multinational medical supply firms while maintaining private ownership and long-term operational focus. Medline is widely recognized for its scale, logistics capabilities, and emphasis on cost-efficient healthcare delivery.

Business Operations

Medline generates revenue through the sale and distribution of medical and surgical products, with operations structured around major business segments including Medical-Surgical Solutions, Patient Care Solutions, Surgical Solutions, and Post-Acute Care Solutions. The company manufactures thousands of private-label products across categories such as infection prevention, wound care, diagnostic equipment, exam gloves, and operating room supplies, complemented by third-party branded products distributed through its logistics network.

Operations are supported by extensive domestic and international infrastructure, including manufacturing facilities, distribution centers, and innovation labs. Medline controls proprietary product technologies, integrated logistics systems, and data-driven supply chain services designed to improve clinical outcomes and reduce provider costs. The company operates numerous subsidiaries focused on regional distribution and specialized product lines, and maintains long-term partnerships with healthcare providers, group purchasing organizations, and clinical systems.

Strategic Position & Investments

Medline’s strategic direction emphasizes organic growth, supply chain expansion, and increased penetration across care settings, particularly in home health, ambulatory surgery, and post-acute care markets. The company has invested heavily in automation, distribution capacity, and digital supply chain tools to enhance service levels and scalability. These investments are intended to strengthen resilience, shorten delivery times, and support large integrated delivery networks.

The company has also pursued selective acquisitions to broaden capabilities and geographic reach. Notable acquisitions include Cardinal Health’s Medical Products distribution assets (acquired in 2021), which significantly expanded Medline’s U.S. distribution footprint. Medline continues to invest in product innovation, infection prevention technologies, and sustainability initiatives, reflecting a long-term strategy centered on operational control and end-to-end healthcare solutions.

Geographic Footprint

Medline is headquartered in North America, with its corporate headquarters in Illinois, United States, and maintains a broad operational presence across the United States. The company operates dozens of distribution centers nationwide, enabling next-day delivery to the majority of U.S. healthcare providers. Its domestic footprint represents the largest share of revenue and operational activity.

Internationally, Medline has established operations across Europe, Asia-Pacific, and Latin America, including manufacturing plants, distribution hubs, and sales offices. The company serves healthcare systems in more than 100 countries through a combination of direct operations and strategic partnerships. Its international investments focus on developed healthcare markets and high-growth regions where demand for cost-effective medical supplies continues to rise.

Leadership & Governance

Medline remains family-owned, with governance reflecting long-term stewardship and operational continuity. The company is led by executives with deep institutional tenure and a strategic philosophy centered on private ownership, reinvestment, and customer-centric supply chain execution. Leadership emphasizes operational excellence, scale efficiency, and sustained investment rather than short-term financial reporting.

Key executives include:

• Jim Abrams – Executive Chairman
• Andy Mills – Chief Executive Officer
• Charlie Mills – President
• Tom Hillebrand – Chief Financial Officer
• Kirk Kamros – Chief Operating Officer
• Joe Smith – Chief Information Officer

The leadership team collectively guides Medline’s strategic vision, balancing growth, operational control, and long-term value creation within the global healthcare ecosystem.